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have demonstrated that percutaneous implantation of
balloon expandable stents offer a safe and effective pal-
liation for obstructed conduits.6-9 In the present study,
we further report our experience with this palliative
strategy and its impact on clinical management.
Methods
Patient selection. Since 1990, the option of transcatheter
endovascular stent implantation within the right ventricular
outflow tract has been offered for patients with right ventri-
cle–to–pulmonary artery conduits when surgical replacement
was considered necessary for management of significant
obstruction. Right ventricular pressure exceeding two thirds of
systemic arterial pressure, as observed on echocardiography,
was considered an indication for intervention, with or without
the presence of symptoms such as effort intolerance or fatigue.
Technique. The technique of implantation has been
described in detail in a previous report.6 Balloon-expandable
stent implants (Palmaz type; Johnson & Johnson Inter-
ventional Systems, Warren, NJ), available in different lengths
(P128 = 12 mm, P188 = 18 mm, P204 = 20 mm, P308 = 30
mm, P4014 = 40 mm, and P5015 = 50 mm), were used,
depending on the diameter and length of the obstruction.
T he placement of extracardiac conduits between thepulmonary ventricle and the pulmonary arteries has
allowed the correction of many complex cardiac
lesions.1,2 These techniques, however, almost always
commit the patient to multiple surgical reinterventions
because of progressive obstruction within the con-
duit.1-5 The cause for these progressive obstructive
lesions include both conduit and valve deterioration,
and the simple fact that small children eventually out-
grow the initially placed conduit.3,5 Previous studies
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Several minor modifications of the original approach have
been incorporated into our present technique. After angio-
graphic and hemodynamic characterization of the obstructive
lesion at cardiac catheterization, the sheath covering the bal-
loon stent is now inserted as a single unit over an exchange
wire from femoral vascular access, improving placement in
the tight curve of the right ventricular outflow tract. Prior bal-
loon dilation of the conduit is not performed unless the con-
duit appears to be heavily calcified. For this study, informed
parental consent was obtained before all procedures.
Follow-up assessment. In the early cohort, a cross-sec-
tional and Doppler echocardiogram was performed within 48
hours after stent placement. This echocardiogram was less
systematically obtained in the latter portion of the series.
After hospital discharge, patients were assessed in the outpa-
tient clinic on a regular basis, as clinically indicated (usually
every 6 months), typically with assessments being made by
means of cross-sectional and Doppler echocardiography.
When feasible, the pressure gradient across the right ventric-
ular outflow tract, the right ventricular pressures (when tri-
cuspid regurgitation was detectable), and the ventricular end-
diastolic dimensions were estimated. A chest radiograph was
obtained when indicated. Repeat cardiac catheterization was
often performed after 1 year, as part of the regular follow-up
in the early experience. Later in our experience, cardiac
catheterization was typically performed when the echocar-
diogram suggested the presence of a significant recurrent
obstruction (right ventricular pressures greater than 66% of
systemic arterial pressure).
Data collection
Initial cardiac catheterization. Hemodynamic data, includ-
ing pressures in the right ventricle and in the main pulmonary
artery, as well as calculation of the ratio of right ventricle to
systemic blood pressure, were recorded before and after stent
implantation. On angiography, the type of conduit stenosis
was classified as “subvalvar,” “valvar,” “supravalvar,” “dif-
fusely small,” or “calcified.” The minimal dimension of the
conduit was measured in the anteroposterior and lateral
angiographic projections, allowing estimation of a minimal
area. The formula used for the area was based on the assump-
tion that the conduit geometry was ellipsoid (Area = p ab,
where a and b are the orthogonal minimal dimensions). This
estimate was made from angiography before and after stent
implantation. The cross-sectional area was expressed as a
percentage of the predicted pulmonary valve orifice area cor-
rected for body surface area.6,10 Immediate complications of
the procedure, technical difficulties, and the fluoroscopy time
were noted.
Follow-up data. Echocardiographic data (right ventricular
pressures and end-diastolic dimensions) and the ratio of right
ventricular to systemic blood pressure assessed immediately
before and after stent implantation, at latest follow-up or
before surgical conduit replacement, were recorded. The right
ventricular end-diastolic dimensions were expressed as z
scores, normalized to body size. Cardiothoracic ratios were
measured from radiographs. For patients who underwent
repeat catheter interventions, procedural details and hemody-
namic and echocardiographic data before and after repeat
catheterization were also recorded.
Data analysis. Patient and procedural characteristics are
described as frequencies, medians with ranges, and means
with standard deviations as appropriate. Where there were
missing data, the number of non-missing values are reported
for that variable. All statistical analyses were performed by
using SAS Version 6.12 statistical software (SAS Institute,
Inc., Cary, NC) with default settings. Changes in hemody-
namic parameters and vascular dimensions were tested with
paired t tests. Outcomes during follow-up were described,
and estimates of freedom from surgical conduit replacement
were plotted by using Kaplan-Meier curves. The effect of
patient and procedural characteristics and acute results on
freedom from surgical conduit replacement were each tested
in Cox’s proportional hazard regression modeling. A proba-
bility value of less than 0.05 was set as the level of statistical
significance.
Results
Patient characteristics. Between July 1990 and
May 1997, 42 patients underwent transcatheter inser-
tion of endovascular stents for relief of obstruction in a
right ventricle–to–pulmonary artery conduit. One
patient underwent a second procedure in a new conduit
after surgical replacement of a previously stented con-
duit. Twenty-four patients were men (57%) and 18
were women (43%). Underlying cardiac diagnoses
consisted of pulmonary atresia with ventricular septal
defect in 16 patients (38%), Fallot’s tetralogy in 10
patients (24%), truncus arteriosus in 7 patients (17%),
transposition of the great arteries with ventricular sep-
tal defect in 5 patients (12%), double outlet right ven-
tricle in 3 patients (7%), and aortic valve stenosis man-
aged with a Ross procedure in 1 patient (2%).
For the remainder of the analysis, the unit of mea-
surement was the 43 episodes of initial stent implanta-
tion, with the 1 patient who had 2 consecutive conduits
and stent implantations counted twice. Twenty-seven
patients (63%) had undergone at least 1 cardiac opera-
tion before the conduit insertion, and 13 patients (30%)
had had their conduits replaced at least once before
endovascular stent placement. The conduits in place at
the time of endovascular stent implantation were pul-
monary homografts in 13 procedures (30%), aortic
homografts in 11 (26%), Polystan valved conduits in
11 (26%), conduits with Symbion or Hancock porcine
valves placed in the orthotopic position in 4 and 1,
respectively (11%), a monocusp patch in a pulmonary
homograft in 1 (2%), and simple enlargement with a
patch in a previously inserted pulmonary homograft in
2 procedures (5%).
The median age at the time of the procedure was 6
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years (range, 0.5 to 17 years), with a median interval
between conduit insertion and endovascular stent place-
ment of 2.4 years (range, 0.3 to 14 years). The median
weight at time of the procedure was 19 kg (range, 6.5 to
58 kg), and median height (n = 38) was 110 cm (range,
63 to 167 cm). Symptoms were noted before the proce-
dure in 11 patients (26%), and these included increased
fatigue, reduced exercise tolerance, and chest pain. One
patient with a ventricular septal defect had increasing
cyanosis. For all patients, the echocardiographic data
and the hemodynamic data at the time of cardiac
catheterization indicated the need for intervention.
Initial procedure
Type of stenosis. Angiographically, conduit stenosis
was subvalvar in 1 patient (2%), valvar in 23 (54%),
supravalvar in 5 (12%), combined valvar and supraval-
var in 9 (21%), and diffuse (small conduit) in 5 (12%).
Extensive calcification within the conduit wall was pres-
ent in 5 patients (12%).
Procedure. Of the 43 procedures, 38 patients had 1
stent inserted within the conduit, 4 patients had 2 stents
placed, and 1 patient had 3 stents. The length of the
implants were 12 mm in 1 patient (2%), 18 mm in 2
(5%), 20 mm in 9 (20%), 30 mm in 28 (65%), 40 mm
in 2 (5%), and 50 mm in 1 patient (2%). The median
maximal balloon diameters used for stent dilation was
15 mm (range, 8 to 20 cm). Larger diameter balloons
were often used at the end of the procedure to flare the
ends of the stents. Mean fluoroscopy time for the pro-
cedure (n = 42) was 40 ± 25 minutes.
The stent covered the valve of the conduit in all but 1
patient, in whom the stent was just above the valvar
ring but kept the leaflets in an open position. The pres-
ence of subvalvar stenosis (at the junction between the
conduit and the right ventricle), isolated in 1 patient
and associated with other locations of stenosis in 5
other patients, did not complicated the procedure and
did not necessitate modifications of the technique.
Hemodynamic and angiographic data. Hemo-
dynamic and angiographic data before and after stent
placement, expressed as mean values ± 1 standard devi-
ation, are shown in Table I.
Mean percentage changes in hemodynamic parame-
ters were noted as follows: right ventricular systolic
pressure, –30% ± 21% (P < .001); ratio of right ventri-
cle to systemic arterial systolic pressure, –36% ± 17%
(n = 38, P < .001); and right ventricle to pulmonary
artery systolic gradients, –60% ± 20% (n = 31, P <
.001). Pulmonary artery systolic pressures increased
slightly, but significantly, with a mean percentage
change of +27% ± 37% (n = 31, P < .001).
The minimal diameter of the conduit increased sig-
nificantly after implantation, with a mean percentage
change of +36% ± 33% (n = 34, P < .001) in the
anteroposterior view and +51% ± 44% (n = 39, P <
.001) in the lateral view. Mean percentage increase for
the percent of predicted pulmonary valve cross-sec-
tional area for body size was +133% ± 107% (n = 31,
P < .001; Table I).
Echocardiographic data. The data from echocardio-
Table I. Hemodynamic and angiographic results at transcatheter endovascular stent implantation
Before stent After stent P value*
RV systolic pressure (mm Hg) 71 ± 18 (n = 43) 48 ± 15 (n = 43) <.001 (n = 43)
Ratio of RV to systemic arterial systolic pressure 0.76 ± 0.21 (n = 43) 0.46 ± 0.12 (n = 39) <.001 (n = 38)
RVOT peak to peak systolic gradient (mm Hg) 48 ± 19 (n = 40) 19 ± 13 (n = 33) <.001 (n = 31)
PA pressure (mm Hg) 23 ± 7 (n = 40) 27 ± 8 (n = 33) 0.002 (n = 31)
Minimal diameter conduit in AP view (mm) 7.1 ± 1.8 (n = 34) 9.4 ± 1.9 (n = 39) <.001 (n = 34)
Minimal diameter conduit in LAT view (mm) 6.6 ± 2.2 (n = 39) 9.4 ± 2.1 (n = 41) <.001 (n = 39)
% of predicted minimal PV area for BSA (%) 26 ± 12 (n = 31) 48 ± 17 (n = 38) <.001 (n = 31)
AP view, Anteroposterior angiographic projection; BSA, body surface area; LAT view, lateral angiographic projection, PA, pulmonary artery; RV, right ventricle; RVOT,
right ventricular outflow tract; PV, pulmonary valve.
* From paired t tests.
Table II. Echocardiographic variables before and after transcatheter stent implantation
Before stent After stent P value*
Estimated RV systolic pressure (mm Hg) 70 ± 11 (n = 25) 50 ± 12 (n = 27) <.001 (n = 20)
Ratio of RV to systemic systolic pressure 0.75 ± 0.16 (n = 16) 0.55 ± 0.11 (n = 7) .09 (n = 4)
RVOT peak to peak systolic gradient (mm Hg) 63 ± 17 (n = 39) 38 ± 17 (n = 34) <.001 (n = 33)
RV, Right ventricle; RVOT, right ventricular outflow tract.
* From paired t tests.
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grams, obtained at a median of 2.6 months (range, 1
day to 8.3 years) before (n = 42) and a median of 1 day
(range, < 1 day to 10.8 months) after (n = 39) the stent
implantation, are shown in Table II.
Mean percentage changes in hemodynamic parame-
ters from echocardiograms before and after stent
implantation were noted as follows: right ventricular
pressure estimated by tricuspid insufficiency, –24% ±
24% (n = 20, P < .001); ratio of right ventricle to sys-
temic arterial systolic pressure, –39% ± 24% (n = 4, P
< .05); and Doppler peak instantaneous gradient across
the right ventricular outflow tract, –37% ± 29% (n = 33,
P < .001).
Early complications. In 1 patient, the stent migrated
distally during placement, and a second stent was
implanted across the obstruction. In 1 patient, there was
interference with the catheter course from the femoral
vein because of the presence of a permanent pacing
wire, and this necessitated vascular access from the
neck. In 2 patients, the stent partially covered the origin
of one or both pulmonary artery orifices, but further
dilation of the distal end of the stent avoided obstruc-
tion. In 1 patient, a stenosis persisted at the distal end
of the stent and a second stent was implanted, but the
balloon ruptured such that full expansion of the stent
was not possible. The stent was withdrawn and
implanted in the inferior caval vein. In 2 additional
patients, the balloon ruptured during inflation, necessi-
tating balloon catheter exchange. In 3 patients, posi-
tioning or opening of the stent was suboptimal, leaving
a residual stenosis. The majority of technical difficul-
ties were encountered during the first 3 years of the
reported experience.
Transcatheter reintervention. Fifteen patients had a
second and 2 patients had a third transcatheter inter-
vention after the initial implantation. The second inter-
vention was performed at a median of 1 year (range,
2.2 months to 2.6 years) after the initial stent implanta-
tion procedure. In 12 of these patients, the previously
implanted stent was dilated, and in 3 patients an addi-
tional stent was implanted. The median balloon diame-
ter used was 15 mm (range, 8 to 18 mm). The median
duration of fluoroscopy (n = 13) was 30 minutes
(range, 10 to 118 minutes).
The hemodynamic data obtained at catheterization
and the echocardiographic data from before and after
reintervention are shown in Table III. Mean percentage
changes in hemodynamic parameters were noted as fol-
lows: right ventricular systolic pressure, –19% ± 15%
(n = 13, P < .001); ratio of right ventricle to systemic
arterial systolic pressure, –22% ± 19% (n = 11, P =
.004); and right ventricle to pulmonary artery peak to
peak systolic pressure gradients, –34% ± 31% (n = 6, P
< .05). There were inadequate numbers to allow statis-
tical analysis of echocardiographic data.
In two reintervention procedures, technical difficul-
ties occurred. At 1 procedure, the balloon ruptured as it
was inflating within a previously implanted stent, and a
Table III. Hemodynamic and angiographic results at transcatheter reintervention
Before After P value*
Hemodynamic data
RV systolic pressure (mm Hg) 66 ± 15 (n = 15) 52 ± 11 (n = 13) .002 (n = 13)
Ratio of RV to systemic arterial systolic pressure 0.7 ± 0.1 (n = 12) 0.5 ± 0.2 (n = 12) .007 (n = 11)
RVOT peak to peak systolic pressure gradient (mm Hg) 40 ± 18 (n = 11) 20 ± 7 (n = 9) .03 (n = 6)
Echocardiographic data
Estimated RV systolic pressure (mm Hg) 57 ± 17 (n = 9) 71 ± 15 mm Hg (n = 5) *
Doppler peak instantaneous RVOT systolic gradient 53 ± 19 mm Hg (n = 10) 54 ± 14 mm Hg (n = 7) *
(mm Hg)
RV, Right ventricle; RVOT, right ventricular outflow tract.
* Insufficient data to perform statistical analysis.
Table IV. Echocardiographic parameters at latest follow-up assessment in patients with and without subsequent
conduit replacement
No surgery (n = 23) Surgery (n = 20) P value
Estimated RV systolic pressure (mm Hg) 53 ± 14 (n = 12) 73 ± 12 (n = 9) .003
Ratio of RV to systemic arterial systolic pressure 0.55 ± 0.13 (n = 9) 0.76 ± 0.2 (n = 6) .03
RVOT Doppler peak instantaneous systolic gradient 39 ± 19 (n = 20) 64 ± 21 (n = 13) .002
(mm Hg)
RV, Right ventricle; RVOT, right ventricular outflow tract.
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second balloon could not enlarge the stent further. In
another patient, the previously implanted stent slipped
to the right pulmonary artery. A second stent was then
prepared, the delivery sheath exposed the stent prema-
turely, and the stent was deployed into the iliac vein. A
third stent was implanted, but during balloon inflation
the balloon ruptured, and it was not possible to fully
enlarge the stent.
Of these 15 reintervention procedures, 8 (53%) were
successful in reducing right ventricular systolic pres-
sures or increasing systemic oxygen saturations (1
patient with open ventricular septal defect), allowing
further postponement of surgical intervention. In 2
patients a third transcatheter reintervention was
attempted with stent dilation. However, both proce-
dures were unsuccessful in further decreasing right
ventricular systolic pressures.
Late follow-up and surgical reintervention. One
late sudden death occurred 2.8 years after initial stent
implantation. The patient died at home, and no autopsy
was performed, leaving the question of the cause of
death unanswered.
Over the course of our reported experience, surgical
conduit replacement was performed in 20 patients.
Indication for conduit replacement in those patients was
the presence of right ventricular pressures above two
thirds of systemic arterial pressure as noted on echocar-
diography. Conduit replacement was uneventful in
those 20 patients, and no surgical difficulties or compli-
cations related to the presence of the stents were report-
ed. The median follow-up interval for the remaining 22
patients was 2.2 years (range, 9.6 months to 6 years).
Body growth was maintained during the follow-up
period, with a median weight increase (n = 34) of 4 kg
(range, -0.6 to 22 kg) and a median height increase (n =
30) of 11 cm (range, 0 to 34 cm). Mean weight veloci-
ty (n = 34) was +2.6 ± 2.2 kg per year of follow-up, with
a mean height velocity (n = 30) of +6.3 ± 4.1 cm/y.
For those patients who have not had surgical replace-
ment of their conduits (n = 23), the latest echocardio-
graphic assessment showed a mean estimated right
ventricular systolic pressure (n = 12) of 53 ± 14 mm
Hg, a mean ratio of right ventricle to systemic arterial
systolic pressure (n = 9) of 0.55 ± 0.13 mm Hg, and a
mean Doppler peak instantaneous right ventricular out-
flow tract gradient (n = 20) of 39 ± 19 mm Hg. Table
IV compares the echocardiographic data at latest fol-
low-up for the patients with and without surgical con-
duit replacement.
To determine the effect of transcatheter intervention
on ventricular dilation, right ventricular end-diastolic
dimensions assessed at echocardiography were con-
verted to z scores on the basis of patient age (unpub-
lished normative data from our echocardiographic lab-
oratory) and compared. Comparison of z values of right
ventricular end-diastolic dimension at echocardio-
graphic assessment just before stent implantation (n =
33, +5.7 ± 4.3, P < .001 vs normal) and at the latest
Fig 1. Kaplan Meier plot of freedom from conduit replacement after transcatheter endovascular stent implanta-
tion. Dashed lines, 95% confidence interval.
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echocardiographic assessment before conduit replace-
ment or at latest follow-up (n = 30, +6.1 ± 3.5, P < .001
vs normal) did not show any significant changes (n =
26, P = .48). Likewise, comparison of the mean cardio-
thoracic ratios from chest radiographs before stent
implantation (n = 32, 0.58 ± 0.06) and before surgical
conduit replacement or at latest follow-up (n = 27, 0.58
± 0.04) did not reveal any significant changes (n = 27,
P = .68).
Freedom from conduit replacement. Kaplan-Meier
analysis revealed a freedom from conduit replacement
of 86% at 1 year, 72% at 2 years, and 47% at 4 years
after initial transcatheter stent implantation (Fig 1).
Cox’s proportionate hazard regression modeling was
used to test the effect of individual variables on time to
conduit replacement (Table V). In univariable analysis,
a decreased time to conduit replacement (ie, decreased
duration of palliation with stent implantation) was sig-
nificantly associated with a higher right ventricular sys-
tolic pressure and a higher right ventricular outflow
tract peak to peak systolic gradient both before and
after initial stent implantation, and a lower percentage
of predicted cross-sectional area of minimal conduit
dimension after stent implantation. In stepwise variable
selection, only a lower percentage of predicted cross-
sectional area of minimal conduit dimension after stent
implantation was independently associated with a
reduced time to conduit replacement; after controlling
for this variable, no other variable could be entered sig-
nificantly into the final model.
Discussion
Over the last 30 years, the use of extracardiac valved
conduits between the subpulmonary ventricle and the
pulmonary arteries has allowed for correction of a
number of complex congenital heart lesions. Despite
various technical modifications and the availability of
different types of valved conduits, this technique still
commits the patients to multiple operations. A recent
report published by Stark and colleagues,2 reviewing
405 conduits implanted between 1971 and 1993,
describes an overall conduit survival at 5, 10, and 15
years of 84%, 58%, and 31%, respectively, with con-
duit obstruction being the most frequent reason for sur-
gical reintervention.2,5 Hemodynamic and immunolog-
ic mechanisms may be responsible for calcification and
deterioration occurring at various levels or diffusely
throughout the conduit.3,5 Indeed, in Stark’s recent
study, second and subsequent conduits had shorter sur-
vival than the original implants. The authors hypothe-
sized that adhesions and calcifications present at reoper-
ation made it more difficult to obtain an ideal fit and flow
characteristics at replacement.2 Thus, even if conduit
replacement is considered a low-risk intervention, tech-
niques to prolong conduit survival should be explored.
In our study, all patients required intervention on the
basis of clinical, echocardiographic, or hemodynamic
findings. While stenosis can occur at multiple locations
within the course of the conduit—making Doppler
echocardiographic assessment difficult, and at times
misleading—several clinical studies have shown a
Table V. Factors at initial transcatheter stent implantation associated with time to conduit replacement*
b Coefficient 
n (standard error) P value RR (95% CI)
Pre-implantation
Age at conduit insertion (y) 43 0.0611 (0.0825) .5 1.06 (0.90, 1.46)
Age at stent implantation (y) 43 –0.0106 (0.0541) .8 0.99 (0.89, 1.10)
Interval from conduit insertion to stent implantation (y) 43 –0.1273 (0.1135) .3 0.88 (0.70, 1.10)
Weight (kg) 43 0.0039 (0.0185) .8 1.00 (0.97, 1.04)
Right ventricle systolic pressure (mm Hg) 43 0.0356 (0.0141) .02 1.04 (1.01, 1.07)
Ratio of RV to systemic arterial systolic pressure 43 1.6637 (1.1558) .15 5.28 (0.55, 50.9)
Gradient from RV to PA (mm Hg) 40 0.0277 (0.0140) <.05 1.03 (1.00, 1.06)
Percentage of predicted cross-sectional area of minimal 31 -0.0154 (0.0284) .6 0.99 (0.93, 1.04)
conduit dimension
Ratio of balloon to minimal conduit diameter 40 –2.1798 (1.4747) .14 0.11 (0.02, 2.04)
Post-implantation
Right ventricle systolic pressure (mm Hg) 43 0.0581 (0.0182) .002 1.06 (1.02, 1.10)
Ratio of RV to systemic arterial systolic pressure 39 2.3491 (1.6945) .17 10.5 (0.38, 290)
Gradient from RV to PA (mm Hg) 33 0.0735 (0.0251) .004 1.08 (1.02, 1.13)
Percentage of predicted cross-sectional area of minimal 38 –0.0611 (0.0228) .008 0.94 (0.90, 0.98)
conduit dimension
PA, Pulmonary artery; RR, risk ratio; RV, right ventricle.
* From univariable Cox’s proportionate hazard regression modeling.
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good correlation between gradients obtained by contin-
uous-wave Doppler echocardiography and those
obtained at cardiac catheterization.11,12 However, in
vitro studies have demonstrated that the combination of
decreasing tunnel cross-sectional area with increasing
tunnel length may lead to significant underestimation
of pressure gradients by Doppler echocardiographic
assessment.13 With these limitations in mind, analysis
of right ventricular systolic pressures by means of the
peak velocity of the tricuspid valve regurgitation jet
has, in our experience, been the preferred method of
assessing the presence and progression of conduit
obstruction. In this series, angiography showed the
conduit stenosis to be mainly at valvar and supravalvar
levels (at the site of the anastomosis with the pul-
monary arteries), similar to previous data.3 Such dis-
crete valvar or supravalvar stenoses respond well to
stent implantation, as contrasted with a diffusely small
conduit.
Despite earlier reports showing some relief of con-
duit stenosis with transcatheter balloon angioplasty
alone,14,15 subsequent reports have noted a high inci-
dence of failure of balloon dilation in these cases, com-
pared with other types of right heart obstructions.16,17
In an attempt to confer a reliable enlargement to such
stenotic lesions, Almagor and associates9 were the first
to deploy a stent across a stenotic right heart valved
conduit in baboons. Subsequent clinical studies have
shown that stent implantation could effectively relieve
conduit stenosis and postpone surgical conduit replace-
ment.6-8,18 Our study confirms these previous data, with
a freedom from surgical replacement of 47% at 4 years
after initial stent implantation. Complications were
rare, tolerance was excellent, and, most important, the
growth of the patients was maintained during follow-
up. Compression of a coronary artery is a potential
problem when one is enlarging the native outflow tract
(either by angioplasty or stenting), and this may also be
an issue when one is enlarging a conduit with a stent,
from posterior compression at the level of the right
ventricular free wall. This should be considered if the
original conduit was implanted because of an anom-
alous vessel and the stent would traverse the free wall.
In this series, we did not encounter this constellation,
but it should be addressed with selective coronary
angiography or test balloon dilation with electrocardio-
graphic monitoring, or both, if the anatomic situation
exists.19 Stent fractures, reported by Powell and associ-
ates,8 were not observed, but may develop as a result of
compression by the sternum on an anteriorly placed
conduit and the ventricular mass.
Limitations to more widespread applications,18,20,21
especially in small children, remain the requirement for
the use of large sheaths to introduce the stents and the
use of small stents limited by patient growth. With
improved balloon technology, smaller sheaths may
now be used21,22 and repeat balloon dilation of implant-
ed stents may be safely performed to deal with resteno-
sis and patient growth.23,24 In our study, results of fur-
ther transcatheter reintervention, including balloon
dilation of the initially implanted stent and the implan-
tation of additional stents, were less optimal, with good
clinical results achieved in only 8 of 15 patients. This
is, in part, related to the observation that restenosis
after initial stent implantation is more often caused by
the presence of small conduits, relative to patient
growth, than by a discrete restenosis. In such situations,
where there is no discrete restenosis within the stented
conduit, or no newly acquired obstruction, we would
therefore recommend proceeding with surgical replace-
ment rather than re-dilation, using conventional criteria
for reintervention. Additionally, when surgery did
occur on these stented implants, replacement was not
associated with any technical surgical problem. The
stents were cut across with heavy scissors, and the con-
duits were opened and removed by conventional
approaches. Stents that were placed into pulmonary
arteries were similarly addressed, frequently cut longi-
tudinally and patched.25
Placement of stents across valved conduits causes
free pulmonary valve insufficiency. This can be further
aggravated by more distal obstruction, emphasizing the
importance of assessing the pulmonary flow run-off
and treating distal branch stenosis, if present, before
stent implantation. The long-term effect of free pul-
monary insufficiency on right ventricular function is a
concern. What is gained by the reduction of stress on
the right ventricular myocardium as a result of the
relief of the outflow obstruction could be lost by
increased stress induced by pulmonary insufficiency in
the long-term, as seen in the adult with repaired Fallot’s
tetralogy. However, this form of conduit “rejuvenation”
is not intended as a long-term solution, but as a medi-
um-term palliation to extend conduit life and avoid
early reoperation. Frequently, associated with conduit
obstruction, significant or “free” pulmonary insuffi-
ciency coexists. In such situations, the stent implant
does not worsen the preexisting volume load lesion, but
reduces the systolic component of potential myocardial
dysfunction. Indeed, the development of volume over-
load right ventricular failure is rare during these rela-
tively brief periods when the stent is used to postpone,
but not eliminate, repeat surgery. In our study, free pul-
monary insufficiency was clinically well tolerated, and
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analysis of the right ventricular dimensions, from M-
mode echocardiography, and the cardiothoracic ratios,
from chest radiographs, revealed no significant in-
crease during follow-up.
In conclusion, our study confirms that transcatheter
endovascular stent implantation in obstructed subpul-
monary ventricle–to–pulmonary artery conduits is an
effective and safe palliation. It should be offered to
growing children who are seen with conduit obstruc-
tion, especially when the obstruction is caused by val-
var or supravalvar stenosis. It allows postponement of
surgical conduit replacement, with good clinical toler-
ance and without impairing patient growth.
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